Cervical Cancer Screening Clinical Trial
Official title:
Comparison of the Hologic Genius Digital Diagnostics System With the Liquid-based Cytology (LBC) Manual Microscopic Approach
Quality assurance of the laboratory examinations. Prospective non-interventional study with ThinPrep slides collected during the German Co-Screening Program and routinely sent to the lab to prospectively evaluate the clinical performance of the Hologic Genius Digital Cytology (DC) system vs. the liquid-based cytology (LBC) manual microscopic approach
The cause of cervical cancer is a persistent infection with high-risk types of human papillomavirus (HPV). Cytology has been the gold standard for cervical screening since the introduction of routine screening with the Pap test in the 1950s due to its effect on mortality in regions with screening programs. Since that time, there have been several technological advances (LBC, Imaging) to improve and automate cervical cytology, resulting in increased disease detection and efficiency. The Hologic's Genius Digital Diagnostics System is a CE-IVD (CE-marked in vitro diagnostic device) marked digital cytology platform. For quality assurance and to prospectively evaluate the Hologic Genius Digital Cytology (DC) system in the lab, selected routinely screened and already archived slides will be additionally reviewed with the liquid-based cytology (LBC) manual microscopic approach. Only anonymized results will be evaluated. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05092022 -
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
|
N/A | |
Completed |
NCT00933140 -
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
|
N/A | |
Recruiting |
NCT05314907 -
Acceptability of Self-sampling for Cervical Cancer Screening
|
N/A | |
Recruiting |
NCT04650711 -
Immunohistochemical Staining of p16 for the Screening of Cervical Cancer
|
Phase 2 | |
Recruiting |
NCT06178549 -
Emergency Room HPV Self-Sampling Study (ACT NOW)
|
N/A | |
Recruiting |
NCT06204133 -
Model Study on Cervical Cancer Screening Strategies and Risk Prediction
|
||
Completed |
NCT04237883 -
Primary Care Clinical Excellence Incentive Study
|
N/A | |
Not yet recruiting |
NCT03750214 -
Evaluation of the Biop Colposcopy System's Safety and Performance (Accuracy of Its Registration Procedure)
|
N/A | |
Completed |
NCT03222817 -
HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals
|
N/A | |
Not yet recruiting |
NCT05426642 -
The Effect of E-health Video Towards Enhancing Cervical Cancer Screening
|
N/A | |
Completed |
NCT00461760 -
HPV Testing for Cervical Cancer Screening Study
|
N/A | |
Not yet recruiting |
NCT05286034 -
Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme
|
N/A | |
Recruiting |
NCT05256862 -
Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania
|
||
Recruiting |
NCT05762757 -
Patient-centered Educational Material to Improve Colposcopy Adherence
|
N/A | |
Completed |
NCT02273206 -
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
|
N/A | |
Completed |
NCT03466710 -
Post Colposcopy Management of ASC-US and LSIL Pap Tests
|
N/A | |
Completed |
NCT01287871 -
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
|
N/A | |
Completed |
NCT00224224 -
A Comparison of Primary Care and Traditional Internal Medicine Residents
|
N/A | |
Not yet recruiting |
NCT06229275 -
Study to Evaluate the Effectiveness of the Personal Pap Smear Deviceā¢ for Collection of Cervical Cells
|
Phase 3 | |
Completed |
NCT03012932 -
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
|
N/A |